» Articles » PMID: 22299027

Antibody to P. Falciparum in Pregnancy Varies with Intermittent Preventive Treatment Regime and Bed Net Use

Overview
Journal PLoS One
Date 2012 Feb 3
PMID 22299027
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antibodies towards placental-binding P. falciparum are thought to protect against pregnancy malaria; however, environmental factors may affect antibody development.

Methods And Findings: Using plasma from pregnant Malawian women, we measured IgG against placental-binding P. falciparum parasites by flow cytometry, and related results to intermittent preventive treatment (IPTp) regime, and bed net use. Bed net use was associated with decreased antibody levels at mid-pregnancy but not at 1 month post partum (1 mpp). At 1 mpp a more intensive IPTp regime was associated with decreased antibody levels in primigravidae, but not multigravidae.

Conclusions/significance: Results suggest bed nets and IPTp regime influence acquisition of pregnancy-specific P. falciparum immunity.

Citing Articles

Acquisition of antibodies to Plasmodium falciparum and Plasmodium vivax antigens in pregnant women living in a low malaria transmission area of Brazil.

Kassa M, Hasang W, Barateiro A, Damelang T, Brewster J, Dombrowski J Malar J. 2022; 21(1):360.

PMID: 36457056 PMC: 9714246. DOI: 10.1186/s12936-022-04402-4.


VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy.

Fonseca A, Gonzalez R, Bardaji A, Jairoce C, Ruperez M, Jimenez A Emerg Infect Dis. 2019; 25(10):1851-1860.

PMID: 31538557 PMC: 6759269. DOI: 10.3201/eid2510.181177.


Effect of IPTp on Plasmodium falciparum antibody levels among pregnant women and their babies in a sub-urban coastal area in Ghana.

Stephens J, Kyei-Baafour E, Dickson E, Ofori J, Ofori M, Wilson M Malar J. 2017; 16(1):224.

PMID: 28549426 PMC: 5446726. DOI: 10.1186/s12936-017-1857-1.


IgG isotypic antibodies to crude Plasmodium falciparum blood-stage antigen associated with placental malaria infection in parturient Cameroonian women.

Anchang-Kimbi J, Achidi E, Nkegoum B, Mendimi J, Sverremark-Ekstrom E, Troye-Blomberg M Afr Health Sci. 2017; 16(4):1007-1017.

PMID: 28479893 PMC: 5398447. DOI: 10.4314/ahs.v16i4.17.


Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.

Chandrasiri U, Fowkes F, Beeson J, Richards J, Kamiza S, Maleta K Malar J. 2016; 15(1):547.

PMID: 27829430 PMC: 5103486. DOI: 10.1186/s12936-016-1597-7.


References
1.
Rogerson S, Hviid L, Duffy P, Leke R, Taylor D . Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007; 7(2):105-17. DOI: 10.1016/S1473-3099(07)70022-1. View

2.
Enosse S, Magnussen P, Abacassamo F, Gomez-Olive X, Ronn A, Thompson R . Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique. Malar J. 2008; 7:115. PMC: 2481262. DOI: 10.1186/1475-2875-7-115. View

3.
Serra-Casas E, Menendez C, Bardaji A, Quinto L, Dobano C, Sigauque B . The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J Infect Dis. 2009; 201(1):123-31. DOI: 10.1086/648595. View

4.
van Eijk A, Ayisi J, Ter Kuile F, Otieno J, Misore A, Odondi J . Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health. 2004; 9(3):351-60. DOI: 10.1111/j.1365-3156.2004.01196.x. View

5.
Aitken E, Mbewe B, Luntamo M, Maleta K, Kulmala T, Friso M . Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. J Infect Dis. 2010; 201(9):1316-25. DOI: 10.1086/651578. View